https://www.semanticscholar.org/topic/Monoclonal-T-cell-Receptor-Anti-CD3-scFv-Fusion/1746358
Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100 | Semantic Scholar
A fusion protein containing a modified form of human T-cell receptor (TCR) specific for the gp100 antigen and fused to an anti-CD3 single-chain antibody...
t cell receptor
https://www.prnewswire.com/news-releases/immunocore-to-present-new-data-from-imcgp100-102-trial-in-metastatic-uveal-melanoma-at-2018-asco-annual-meeting-300652275.html
Immunocore to Present New Data from IMCgp100-102 Trial in Metastatic Uveal Melanoma at 2018 ASCO...
/PRNewswire/ -- Immunocore Limited, a leading T cell receptor (TCR) company focused on delivering first-in-class biological therapies that have the potential...
https://www.prnewswire.com/news-releases/immunocores-imcgp100-accepted-for-adaptive-pathway-pilot-programme-525859981.html
Immunocore's IMCgp100 Accepted for Adaptive Pathway Pilot Programme
/PRNewswire/ -- Potential for Accelerated Regulatory Approval in Europe Immunocore Limited, a world-leading biotechnology company developing novel T cell...
immunocoreimcgp100acceptedadaptivepathway
https://www.prnewswire.com/news-releases/immunocore-to-present-imcgp100-clinical-trial-data-at-aacr-annual-meeting-2015-499005961.html
Immunocore to Present IMCgp100 Clinical Trial Data at AACR Annual Meeting 2015
/PRNewswire/ -- ~ A Phase I/IIa study of IMCgp100: partial and complete durable responses with a novel first-in-class immunotherapy for advanced melanoma ~...
clinical trial dataaacr annual meeting